While we attempted to identify LNM-specific mutation profiles, there were no significant differences in mutation rates among the top 3 CRC driver genes, TP53, APC and KRAS (p = 0.811, p = 0.518 and p = 0.981, respectively). This evidence concerns the gene KRAS and colorectal carcinoma.